The Latest
-
Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey
“We have all this data that’s available, but it’s actually not actionable because we don’t have a way to get it into clinical workflow,” said American Medical Association CEO Dr. John Whyte.
-
Top surgical robotics stories in the first half of 2026
The market for robotic surgery got more competitive this year, with Medtronic, Stryker, CMR Surgical and Distalmotion introducing new platforms. Check up on their progress and more in MedTech Dive’s roundup of robotics coverage.
-
Penumbra starts trial of clot removal device in stroke subgroup
Penumbra, which is set to become part of Boston Scientific this year, is running the trial to inform the treatment of a type of medium-vessel blockage.
-
AdaptHealth discloses patient data was stolen in cyberattack
The medical device supplier said that a threat actor accessed company systems through a social engineering attack.
-
Top 10 medtech deals in the first half of 2026
Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding quickly.
-
Insulet launches Omnipod 5 in Spain
A high rate of continuous glucose monitor adoption and low level of automated insulin delivery system penetration make Spain an attractive market for Insulet.
-
Top diabetes tech stories from the first half of 2026
Diabetes technology news has been off to a fast start this year. Here are some highlights of MedTech Dive’s coverage from 2026.
-
Medtronic starts to notify people affected by cyberattack
The medtech giant said it currently has no evidence that the accessed data has been posted to the internet.
-
Medicare slashes 340B payments, broadens site-neutral policies in proposed 2027 payment rule
The rule, released Thursday, builds on Trump administration priorities, including cutting Medicare reimbursement for drugs in the controversial 340B program and equalizing payment between sites of care.
-
Guardant’s Shield colon cancer blood test snags UnitedHealth coverage
One analyst called the insurer’s decision a “watershed moment” for liquid biopsy-based cancer screening and for the category of blood-based cancer testing.
-
Terumo recalls stent-graft system linked to three deaths
Terumo has yet to establish a direct causal relationship between the deaths and the delivery system separation issues.
-
FDA authorizes more devices so far in 2026, but it’s taking longer
Original premarket approvals are taking “substantially longer” than last year, according to a report from BTIG.
-
Top medtech conferences in 2026
After a busy first half of the year, there are still plenty of medtech events to look forward to, including AdvaMed’s annual meeting in Boston.
Updated June 29, 2026 -
US blocks quick USMCA extension, putting annual review process into motion
The U.S., Mexico and Canada will continue negotiating about potential adjustments to the trilateral free trade agreement, which will remain in place until at least 2036.
-
Retrieved from Hologic on January 16, 2025
FDA updates Hologic BioZorb recall, citing 252 injuries
While the company no longer manufactures the radiographic markers, healthcare providers are still advised to monitor patients who have had them implanted.
-
Roche takes on Illumina with new NGS system
When Roche previewed the Axelios technology in February, a Jefferies analyst called the next-generation sequencing platform the “greatest credible competitive threat in years.”
-
Zimmer to buy Pacira pain relief device for up to $140M
Pacira’s iovera device uses cold therapy for targeted pain relief. An analyst said the addition complements Zimmer Biomet’s portfolio.
-
DePuy Synthes names CFO ahead of J&J split
Christina Zamarro will take over the role in July after spending nearly 20 years at Goodyear Tire & Rubber Company, most recently serving as its CFO.
-
Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic
Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.
-
J&J starts pivotal trials of Shockwave IVL device in carotid arteries
J&J is working to expand use of Shockwave’s technology as competition in intravascular lithotripsy builds from companies like Boston Scientific and Stryker.
-
Aidoc wins breakthrough nod for AI that reads chest X-rays
Aidoc is working on an artificial intelligence feature that would analyze chest X-rays and generate preliminary reports for more than 100 findings.
-
Q&A
BD’s Bilal Muhsin talks AI in connected care
Muhsin discussed how BD is rolling out a new medication dispenser and a software platform that pulls together data from the company’s various devices.
Updated June 25, 2026 -
Agilent finalizes Biocare Medical takeover
The acquisition strengthens Agilent’s presence in areas including cancer and infectious disease diagnostic and research markets.
-
Labcorp rolls out colorectal cancer screening test nationwide
The Geneoscopy test competes with Exact Sciences’ Cologuard for the U.S. colorectal cancer screening market.
-
Tissium secures up to $68M to back rollout of nerve repair platform
The MIT spinout will use the financing, from investors and the European Investment Bank, to accelerate the U.S. launch of its Coaptium sutureless nerve repair technology.